Статті в журналах з теми "T1AM"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "T1AM".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Rogowski, Michael, Lorenza Bellusci, Martina Sabatini, Simona Rapposelli, Shaikh M. Rahman, Grazia Chiellini, and Fariba M. Assadi-Porter. "Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway." International Journal of Molecular Sciences 20, no. 16 (August 20, 2019): 4054. http://dx.doi.org/10.3390/ijms20164054.
Повний текст джерелаSaba, Alessandro, Grazia Chiellini, Sabina Frascarelli, Maja Marchini, Sandra Ghelardoni, Andrea Raffaelli, Massimo Tonacchera, Paolo Vitti, Thomas S. Scanlan, and Riccardo Zucchi. "Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine." Endocrinology 151, no. 10 (August 25, 2010): 5063–73. http://dx.doi.org/10.1210/en.2010-0491.
Повний текст джерелаDinter, Juliane, Noushafarin Khajavi, Jessica Mühlhaus, Carolin Leonie Wienchol, Maxi Cöster, Thomas Hermsdorf, Claudia Stäubert та ін. "The Multitarget Ligand 3-Iodothyronamine Modulates β-Adrenergic Receptor 2 Signaling". European Thyroid Journal 4, Suppl. 1 (2015): 21–29. http://dx.doi.org/10.1159/000381801.
Повний текст джерелаGhelardoni, Sandra, Grazia Chiellini, Sabina Frascarelli, Alessandro Saba, and Riccardo Zucchi. "Uptake and metabolic effects of 3-iodothyronamine in hepatocytes." Journal of Endocrinology 221, no. 1 (April 2014): 101–10. http://dx.doi.org/10.1530/joe-13-0311.
Повний текст джерелаDinter, Juliane, Jessica Mühlhaus, Simon Friedrich Jacobi, Carolin Leonie Wienchol, Maxi Cöster, Jaroslawna Meister, Carolin Stephanie Hoefig та ін. "3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling". Journal of Molecular Endocrinology 54, № 3 (червень 2015): 205–16. http://dx.doi.org/10.1530/jme-15-0003.
Повний текст джерелаHaiyan, Zhou, Hu Bailong, Zhang Bei, Wang Yiming, and Liu Xingde. "Comparative Transcriptome Analysis Reveals the Potential Cardiovascular Protective Targets of the Thyroid Hormone Metabolite 3-Iodothyronamine (3-T1AM)." BioMed Research International 2020 (June 20, 2020): 1–10. http://dx.doi.org/10.1155/2020/1302453.
Повний текст джерелаCöster, Maxi, Heike Biebermann, Torsten Schöneberg, and Claudia Stäubert. "Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1." European Thyroid Journal 4, Suppl. 1 (2015): 9–20. http://dx.doi.org/10.1159/000430839.
Повний текст джерелаGencarelli, Manuela, Annunziatina Laurino, Elisa Landucci, Daniela Buonvicino, Costanza Mazzantini, Grazia Chiellini, and Laura Raimondi. "3-Iodothyronamine Affects Thermogenic Substrates’ Mobilization in Brown Adipocytes." Biology 9, no. 5 (May 4, 2020): 95. http://dx.doi.org/10.3390/biology9050095.
Повний текст джерелаGalli, Elena, Maja Marchini, Alessandro Saba, Sergio Berti, Massimo Tonacchera, Paolo Vitti, Thomas S. Scanlan, Giorgio Iervasi, and Riccardo Zucchi. "Detection of 3-Iodothyronamine in Human Patients: A Preliminary Study." Journal of Clinical Endocrinology & Metabolism 97, no. 1 (January 1, 2012): E69—E74. http://dx.doi.org/10.1210/jc.2011-1115.
Повний текст джерелаHackenmueller, Sarah A., Maja Marchini, Alessandro Saba, Riccardo Zucchi, and Thomas S. Scanlan. "Biosynthesis of 3-Iodothyronamine (T1AM) Is Dependent on the Sodium-Iodide Symporter and Thyroperoxidase but Does Not Involve Extrathyroidal Metabolism of T4." Endocrinology 153, no. 11 (November 1, 2012): 5659–67. http://dx.doi.org/10.1210/en.2012-1254.
Повний текст джерелаAgretti, Patrizia, Giuseppina De Marco, Laura Russo, Alessandro Saba, Andrea Raffaelli, Maja Marchini, Grazia Chiellini, et al. "3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells." Journal of Molecular Endocrinology 47, no. 1 (April 21, 2011): 23–32. http://dx.doi.org/10.1530/jme-10-0168.
Повний текст джерелаScanlan, Thomas S. "3-Iodothyronamine (T1AM): A New Player on the Thyroid Endocrine Team?" Endocrinology 150, no. 3 (December 30, 2008): 1108–11. http://dx.doi.org/10.1210/en.2008-1596.
Повний текст джерелаGencarelli, Manuela, Maura Lodovici, Lorenza Bellusci, Laura Raimondi, and Annunziatina Laurino. "Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1)." International Journal of Molecular Sciences 23, no. 5 (February 28, 2022): 2718. http://dx.doi.org/10.3390/ijms23052718.
Повний текст джерелаAckermans, M. T., L. P. Klieverik, P. Ringeling, E. Endert, A. Kalsbeek, and E. Fliers. "An online solid-phase extraction–liquid chromatography–tandem mass spectrometry method to study the presence of thyronamines in plasma and tissue and their putative conversion from 13C6-thyroxine." Journal of Endocrinology 206, no. 3 (July 5, 2010): 327–34. http://dx.doi.org/10.1677/joe-10-0060.
Повний текст джерелаRutigliano, Grazia, Lavinia Bandini, Simona Sestito, and Grazia Chiellini. "3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?" International Journal of Molecular Sciences 21, no. 6 (March 15, 2020): 2005. http://dx.doi.org/10.3390/ijms21062005.
Повний текст джерелаdi Leo, Nicoletta, Stefania Moscato, Marco Borso', Simona Sestito, Beatrice Polini, Lavinia Bandini, Agostina Grillone, et al. "Delivery of Thyronamines (TAMs) to the Brain: A Preliminary Study." Molecules 26, no. 6 (March 14, 2021): 1616. http://dx.doi.org/10.3390/molecules26061616.
Повний текст джерелаBandini, Lavinia, Ginevra Sacripanti, Marco Borsò, Maria Tartaria, Maria Pia Fogliaro, Giulia Giannini, Vittoria Carnicelli, et al. "Exogenous 3-Iodothyronamine (T1AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA1)." Life 12, no. 9 (August 30, 2022): 1352. http://dx.doi.org/10.3390/life12091352.
Повний текст джерелаBiebermann, Heike, and Gunnar Kleinau. "3-Iodothyronamine Induces Diverse Signaling Effects at Different Aminergic and Non-Aminergic G-Protein Coupled Receptors." Experimental and Clinical Endocrinology & Diabetes 128, no. 06/07 (November 7, 2019): 395–400. http://dx.doi.org/10.1055/a-1022-1554.
Повний текст джерелаHoefig, Carolin S., Tilo Wuensch, Eddy Rijntjes, Ina Lehmphul, Hannelore Daniel, Ulrich Schweizer, Jens Mittag, and Josef Köhrle. "Biosynthesis of 3-Iodothyronamine From T4 in Murine Intestinal Tissue." Endocrinology 156, no. 11 (September 8, 2015): 4356–64. http://dx.doi.org/10.1210/en.2014-1499.
Повний текст джерелаChiellini, Grazia, Paola Erba, Vittoria Carnicelli, Chiara Manfredi, Sabina Frascarelli, Sandra Ghelardoni, Giuliano Mariani, and Riccardo Zucchi. "Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors." Journal of Endocrinology 213, no. 3 (March 22, 2012): 223–30. http://dx.doi.org/10.1530/joe-12-0055.
Повний текст джерелаWei, Bo, Hanbing Zhao, Bailong Hu, Lujun Dai, Guoning Zhang, Lili Mo, Niwen Huang, et al. "T1AM Attenuates the Hypoxia/Reoxygenation-Induced Necroptosis of H9C2 Cardiomyocytes via RIPK1/RIPK3 Pathway." BioMed Research International 2022 (February 28, 2022): 1–8. http://dx.doi.org/10.1155/2022/4833791.
Повний текст джерелаDiab, Nour, Sameer Desale, Mark Danielsen, Josef Köhrle, Nawar Shara, and Jacqueline Jonklaas. "Changes in Thyroid Metabolites after Liothyronine Administration: A Secondary Analysis of Two Clinical Trials That Incorporated Pharmacokinetic Data." Metabolites 12, no. 6 (May 24, 2022): 476. http://dx.doi.org/10.3390/metabo12060476.
Повний текст джерелаKlieverik, Lars P., Ewout Foppen, Mariëtte T. Ackermans, Mireille J. Serlie, Hans P. Sauerwein, Thomas S. Scanlan, David K. Grandy, Eric Fliers, and Andries Kalsbeek. "Central effects of thyronamines on glucose metabolism in rats." Journal of Endocrinology 201, no. 3 (March 6, 2009): 377–86. http://dx.doi.org/10.1677/joe-09-0043.
Повний текст джерелаHomuth, Georg, Julika Lietzow, Nancy Schanze, Janine Golchert, and Josef Köhrle. "Endocrine, Metabolic and Pharmacological Effects of Thyronamines (TAM), Thyroacetic Acids (TA) and Thyroid Hormone Metabolites (THM) – Evidence from in vitro, Cellular, Experimental Animal and Human Studies." Experimental and Clinical Endocrinology & Diabetes 128, no. 06/07 (May 25, 2020): 401–13. http://dx.doi.org/10.1055/a-1139-9200.
Повний текст джерелаBellusci, Lorenza, Massimiliano Runfola, Vittoria Carnicelli, Simona Sestito, Federica Fulceri, Filippo Santucci, Paola Lenzi, et al. "Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6." Molecules 25, no. 5 (February 26, 2020): 1054. http://dx.doi.org/10.3390/molecules25051054.
Повний текст джерелаScanlan, Thomas S. "Endogenous 3-Iodothyronamine (T1AM): More Than We Bargained For." Journal of Clinical Endocrinology & Metabolism 96, no. 6 (June 2011): 1674–76. http://dx.doi.org/10.1210/jc.2011-0688.
Повний текст джерелаLaurino, Annunziatina, Rosanna Matucci, Giulio Vistoli, and Laura Raimondi. "3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors." European Journal of Pharmacology 793 (December 2016): 35–42. http://dx.doi.org/10.1016/j.ejphar.2016.10.027.
Повний текст джерелаStavrou, Stavroula, Michael Gratz, Eileen Tremmel, Christina Kuhn, Simone Hofmann, Helene Heidegger, Mina Peryanova та ін. "TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC". Endocrine Connections 7, № 2 (лютий 2018): 372–84. http://dx.doi.org/10.1530/ec-17-0272.
Повний текст джерелаMiyakawa, Motonori, and Thomas S. Scanlan. "Synthesis of [125I]‐, [2H]‐, and [3H]‐Labeled 3‐Iodothyronamine (T1AM)." Synthetic Communications 36, no. 7 (March 1, 2006): 891–902. http://dx.doi.org/10.1080/00397910500466074.
Повний текст джерелаIanculescu, Alexandra G., and Thomas S. Scanlan. "3-Iodothyronamine (T1AM): a new chapter of thyroid hormone endocrinology?" Molecular BioSystems 6, no. 8 (2010): 1338. http://dx.doi.org/10.1039/b926583j.
Повний текст джерелаGratz, Michael J., Stavroula Stavrou, Christina Kuhn, Simone Hofmann, Kerstin Hermelink, Helene Heidegger, Stefan Hutter, et al. "Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages." Endocrine Connections 7, no. 5 (May 2018): 727–38. http://dx.doi.org/10.1530/ec-18-0126.
Повний текст джерелаTozzi, Francesca, Grazia Rutigliano, Marco Borsò, Chiara Falcicchia, Riccardo Zucchi, and Nicola Origlia. "T1AM-TAAR1 signalling protects against OGD-induced synaptic dysfunction in the entorhinal cortex." Neurobiology of Disease 151 (April 2021): 105271. http://dx.doi.org/10.1016/j.nbd.2021.105271.
Повний текст джерелаla Cour, Jeppe Lerche, Heidi M. Christensen, Josef Köhrle, Ina Lehmphul, Caroline Kistorp, Birte Nygaard, and Jens Faber. "Association Between 3-Iodothyronamine (T1am) Concentrations and Left Ventricular Function in Chronic Heart Failure." Journal of Clinical Endocrinology & Metabolism 104, no. 4 (October 31, 2018): 1232–38. http://dx.doi.org/10.1210/jc.2018-01466.
Повний текст джерелаChiellini, Grazia, Sandra Ghelardoni, Sabina Frascarelli, Simonetta Testoni, Thomas S. Scanlan, David K. Grandy, and Riccardo Zucchi. "3-Iodothyronamine (T1AM) induces variation in phosphorylation pattern of tyrosine residues in rat heart." Journal of Molecular and Cellular Cardiology 44, no. 4 (April 2008): 773–74. http://dx.doi.org/10.1016/j.yjmcc.2008.02.149.
Повний текст джерелаGonçalves, Luís M., Manuela M. Moreira, Carla F. Azevedo, Inês M. Valente, João C. Sousa, Thomas S. Scanlan, Richard G. Compton, and José A. Rodrigues. "Proof of Concept of the Electrochemical Sensing of 3-Iodothyronamine (T1AM) and Thyronamine (T0AM)." ChemElectroChem 1, no. 10 (August 25, 2014): 1623–26. http://dx.doi.org/10.1002/celc.201402165.
Повний текст джерелаLi, Zhong-Min, Manuel Miller, Sogol Gachkar, Jens Mittag, Sonja C. Schriever, Paul T. Pfluger, Karl-Werner Schramm, and Meri De Angelis. "Determination of 3-iodothyronamine (3-T1AM) in mouse liver using liquid chromatography-tandem mass spectrometry." Journal of Chromatography B 1165 (February 2021): 122553. http://dx.doi.org/10.1016/j.jchromb.2021.122553.
Повний текст джерелаLangouche, Lies, Ina Lehmphul, Sarah Vander Perre, Josef Köhrle, and Greet Van den Berghe. "Circulating 3-T1AM and 3,5-T2 in Critically Ill Patients: A Cross-Sectional Observational Study." Thyroid 26, no. 12 (December 2016): 1674–80. http://dx.doi.org/10.1089/thy.2016.0214.
Повний текст джерелаLaurino, Annunziatina, Ersilia Lucenteforte, Gaetano De Siena, and Laura Raimondi. "The impact of scopolamine pretreatment on 3-iodothyronamine (T1AM) effects on memory and pain in mice." Hormones and Behavior 94 (August 2017): 93–96. http://dx.doi.org/10.1016/j.yhbeh.2017.07.003.
Повний текст джерелаLaurino, Annunziatina, Manuela Gencarelli, and Laura Raimondi. "The 3-iodothyronamine (T1AM) and the 3-iodothyroacetic acid (TA1) indicate a novel connection with the histamine system for neuroprotection." European Journal of Pharmacology 912 (December 2021): 174606. http://dx.doi.org/10.1016/j.ejphar.2021.174606.
Повний текст джерелаManni, Maria Elena, Gaetano De Siena, Alessandro Saba, Maja Marchini, Elisa Landucci, Elisabetta Gerace, Marina Zazzeri, et al. "Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold." British Journal of Pharmacology 168, no. 2 (December 20, 2012): 354–62. http://dx.doi.org/10.1111/j.1476-5381.2012.02137.x.
Повний текст джерелаAssadi-Porter, Fariba, Hannah Reiland, Martina Sabatini, Leonardo Lorenzini, Vittoria Carnicelli, Micheal Rogowski, Ebru Selen Alpergin, et al. "Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression." International Journal of Molecular Sciences 19, no. 5 (May 22, 2018): 1535. http://dx.doi.org/10.3390/ijms19051535.
Повний текст джерелаLanducci, Elisa, Manuela Gencarelli, Costanza Mazzantini, Annunziatina Laurino, Domenico Edoardo Pellegrini-Giampietro, and Laura Raimondi. "N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity." Neurochemistry International 129 (October 2019): 104460. http://dx.doi.org/10.1016/j.neuint.2019.05.004.
Повний текст джерелаHan, Hong-Seok, Hyun-June Paik, Jai Min Ryu, Sungmin Park, Ha Woo Yi, Suyeon Bae, Sekyung Lee, et al. "Comparison of prognosis and specific features according to tumor size in small-sized breast cancer with extensive lymph node involvement." Journal of Clinical Oncology 33, no. 28_suppl (October 1, 2015): 81. http://dx.doi.org/10.1200/jco.2015.33.28_suppl.81.
Повний текст джерелаLaurino, Annunziatina, Gaetano De Siena, Alessandro Saba, Grazia Chiellini, Elisa Landucci, Riccardo Zucchi, and Laura Raimondi. "In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine." European Journal of Pharmacology 761 (August 2015): 130–34. http://dx.doi.org/10.1016/j.ejphar.2015.04.038.
Повний текст джерелаVogelsang, Tilman L. R., Aurelia Vattai, Elisa Schmoeckel, Till Kaltofen, Anca Chelariu-Raicu, Mingjun Zheng, Sven Mahner, Doris Mayr, Udo Jeschke, and Fabian Trillsch. "Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer." International Journal of Molecular Sciences 22, no. 16 (August 6, 2021): 8479. http://dx.doi.org/10.3390/ijms22168479.
Повний текст джерелаDietrich, Johannes W., Patrick Müller, Fabian Schiedat, Markus Schlömicher, Justus Strauch, Apostolos Chatzitomaris, Harald H. Klein, et al. "Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling." European Thyroid Journal 4, no. 2 (2015): 129–37. http://dx.doi.org/10.1159/000381543.
Повний текст джерелаRathmann, Daniel, Eddy Rijntjes, Julika Lietzow, and Josef Köhrle. "Quantitative Analysis of Thyroid Hormone Metabolites in Cell Culture Samples Using LC-MS/MS." European Thyroid Journal 4, Suppl. 1 (2015): 51–58. http://dx.doi.org/10.1159/000430840.
Повний текст джерелаFehrenbacher, Louis, Angela M. Capra, Charles P. Quesenberry, Regan Fulton, Parveen Shiraz, and Laurel A. Habel. "Distant Invasive Breast Cancer Recurrence Risk in Human Epidermal Growth Factor Receptor 2–Positive T1a and T1b Node-Negative Localized Breast Cancer Diagnosed From 2000 to 2006: A Cohort From an Integrated Health Care Delivery System." Journal of Clinical Oncology 32, no. 20 (July 10, 2014): 2151–58. http://dx.doi.org/10.1200/jco.2013.52.0858.
Повний текст джерелаKanayama, Naoki, Mitsuyoshi Ueda, Haruyuki Atomi, and Atsuo Tanaka. "Genetic Evaluation of Physiological Functions of Thiolase Isozymes in the n-Alkane-Assimilating YeastCandida tropicalis." Journal of Bacteriology 180, no. 3 (February 1, 1998): 690–98. http://dx.doi.org/10.1128/jb.180.3.690-698.1998.
Повний текст джерелаOyama, Tsuneo, and Akiko Takahashi. "PS02.025: CHARACTERISTICS OF SUPERFICIAL BASALOID SQUAMOUS CELL CARCINOMA TREATED BY ENDOSCOPIC RESECTION." Diseases of the Esophagus 31, Supplement_1 (September 1, 2018): 127. http://dx.doi.org/10.1093/dote/doy089.ps02.025.
Повний текст джерела